Astrana Health (ASTH) Equity Average (2011 - 2026)

Astrana Health (ASTH) has 16 years of Equity Average data on file, last reported at $797.2 million in Q1 2026.

• Quarterly Equity Average rose 8.68% year-over-year to $797.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $797.2 million (up 8.68% YoY) and the FY2025 annual result came in at $748.0 million, up 12.2% from the prior year.
• Equity Average climbed to $797.2 million in Q1 2026 per ASTH's latest filing, from $777.4 million in the prior quarter.
• The five-year high for Equity Average was $797.2 million in Q1 2026, with the low at $463.4 million in Q1 2022.
• Average Equity Average over 5 years is $636.2 million, with a median of $637.3 million recorded in 2024.
• Year-over-year, Equity Average soared 36.99% in 2022 and grew 8.68% in 2026.
• Astrana Health's Equity Average stood at $524.3 million in 2022, then increased by 15.8% to $607.2 million in 2023, then climbed by 17.46% to $713.2 million in 2024, then advanced by 9.01% to $777.4 million in 2025, then gained by 2.55% to $797.2 million in 2026.
• Business Quant data shows ASTH's Equity Average at $797.2 million in Q1 2026, $777.4 million in Q4 2025, and $773.5 million in Q3 2025.